T Kosaka Selected Research

T Kosaka Research Topics

Disease

5	Neoplasms (Cancer) 11/2016 - 04/2000
3	Inflammation (Inflammations) 07/2013 - 08/2006
3	Infections 04/2002 - 02/2000
2	Asthma (Bronchial Asthma) 07/2013 - 11/2011
2	Allergic Rhinitis 07/2013 - 11/2011
2	Dermatitis 09/2012 - 11/2011
2	Stomach Neoplasms (Stomach Cancer) 02/2011 - 06/2009
2	Crohn Disease (Crohn's Disease) 12/2005 - 06/2001
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2005 - 08/2003
1	Esophageal Neoplasms (Esophageal Cancer) 11/2016
1	Lymphedema (Milroy Disease) 05/2016
1	Hemorrhagic Cystitis 11/2015
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Hypersensitivity (Allergy) 07/2013
1	Carcinoma (Carcinomatosis) 06/2013
1	Edema (Dropsy) 09/2012
1	Erythema 09/2012
1	Atopic Dermatitis (Atopic Eczema) 11/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2011
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2011
1	Atrophy 03/2011
1	Pancreaticobiliary Maljunction 04/2010
1	Demyelinating Diseases (Demyelinating Disease) 11/2009
1	Multiple Sclerosis 11/2009
1	Myelitis 11/2009
1	Neuromyelitis Optica (Devic's Disease) 11/2009
1	Optic Neuritis (Retrobulbar Neuritis) 11/2009
1	Fibrosis (Cirrhosis) 08/2006
1	Gingival Overgrowth 08/2006
1	Disease Susceptibility (Diathesis) 12/2005
1	Ulcerative Colitis 12/2005
1	Proctitis 12/2005
1	Hyperthyroidism 08/2003
1	Lymphocytic Colitis 08/2003
1	Autoimmune enteropathy 08/2003
1	Type 2 Diabetes Mellitus (MODY) 10/2002

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 09/2012 - 01/2000
3	Methoxychlor (Metox)IBA 07/2013 - 03/2011
3	Immunoglobulin G (IgG)IBA 09/2012 - 11/2009
2	Parathion (Ethyl Parathion)IBA 07/2013 - 11/2011
2	AllergensIBA 07/2013 - 11/2011
2	Therapeutic UsesIBA 06/2013 - 11/2000
2	Immunoglobulin E (IgE)IBA 09/2012 - 11/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 11/2000
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2011 - 03/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011 - 04/2000
2	AutoantibodiesIBA 11/2009 - 08/2003
1	Indicators and Reagents (Reagents)IBA 11/2016
1	cabazitaxel FDA Link 11/2015
1	Piperonyl Butoxide FDA Link 07/2013
1	OvalbuminIBA 07/2013
1	bcl-X ProteinIBA 06/2013
1	Picryl Chloride (Trinitrochlorobenzene)IBA 09/2012
1	Angiotensin Receptor AntagonistsIBA 01/2012
1	Surface Antigens (Surface Antigen)IBA 11/2011
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	Type 1 Angiotensin ReceptorIBA 10/2011
1	PlatinumIBA 10/2011
1	Angiotensin IIIBA 10/2011
1	Secretory Proteinase Inhibitory ProteinsIBA 07/2011
1	SodiumIBA 07/2011
1	C-Reactive ProteinIBA 07/2011
1	sivelestatIBA 07/2011
1	CollagenIBA 06/2011
1	PesticidesIBA 03/2011
1	Hormones (Hormone)IBA 03/2011
1	Docetaxel (Taxotere)FDA Link 02/2011
1	Cisplatin (Platino)FDA LinkGeneric 02/2011
1	phytobacteriomycin (PBM)IBA 04/2010
1	Aquaporins (Water Channels)IBA 11/2009
1	Interleukin-6 (Interleukin 6)IBA 11/2009
1	InterleukinsIBA 11/2009
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 08/2006
1	Interleukin-1 (Interleukin 1)IBA 08/2006
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 08/2006
1	Collagen Type I (Type I Collagen)IBA 08/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2006
1	Nifedipine (Adalat)FDA LinkGeneric 08/2006
1	Interleukin-18 (Interleukin 18)IBA 12/2005
1	Messenger RNA (mRNA)IBA 12/2005
1	A 19IBA 08/2003
1	Immunoglobulin A (IgA)IBA 08/2003
1	HDL CholesterolIBA 10/2002
1	Glucose (Dextrose)FDA LinkGeneric 10/2002
1	EnzymesIBA 10/2002
1	Insulin (Novolin)FDA Link 10/2002
1	LipidsIBA 10/2002
1	LDL CholesterolIBA 10/2002
1	Platelet Activating FactorIBA 10/2002
1	Triglycerides (Triacylglycerol)IBA 10/2002

Therapy/Procedure

4	Therapeutics 04/2015 - 11/2000
3	Lymph Node Excision (Lymph Node Dissection) 05/2016 - 07/2011
2	Segmental Mastectomy (Lumpectomy) 07/2016 - 04/2015
1	Chemoradiotherapy 11/2016
1	Radiotherapy 11/2015
1	Artificial Respiration (Mechanical Ventilation) 07/2011
1	Length of Stay 07/2011
1	Drug Therapy (Chemotherapy) 02/2011
1	Gastrectomy 06/2009